Literature DB >> 19747748

Fasting plasma glucose variability as a marker of nocturnal hypoglycemia in diabetes: evidence from the PREDICTIVE study.

Leo Niskanen1, Antti Virkamäki, Jes B Hansen, Tero Saukkonen.   

Abstract

The relationship between fasting glucose (FG) variability and nocturnal hypoglycemia was assessed using longitudinal data from PREDICTIVE, the large-scale observational study of insulin detemir. An HbA(1c)-corrected correlation was found between these endpoints, suggesting FG variability can serve as a useful marker for this risk in clinical practice.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19747748     DOI： 10.1016/j.diabres.2009.08.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  15 in total

1.  Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.

Authors:  Kathleen Dungan; Philip Binkley; Kwame Osei
Journal:  J Diabetes Complications       Date:  2015-09-21       Impact factor: 2.852

Review 2.  New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk.

Authors:  Jin J Zhou; Daniel S Nuyujukian; Peter D Reaven
Journal:  Curr Cardiol Rep       Date:  2021-03-02       Impact factor: 2.931

Review 3.  Glucose variability, HbA1c and microvascular complications.

Authors:  Jan Škrha; Jan Šoupal; Jan Škrha; Martin Prázný
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

4.  Effect of the approach to insulin therapy on glycaemic fluctuations and autonomic tone in hospitalized patients with diabetes.

Authors:  K M Dungan; K Osei; C Sagrilla; P Binkley
Journal:  Diabetes Obes Metab       Date:  2013-02-17       Impact factor: 6.577

5.  Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial.

Authors:  Jin J Zhou; Dawn C Schwenke; Gideon Bahn; Peter Reaven
Journal:  Diabetes Care       Date:  2018-08-06       Impact factor: 19.112

Review 6.  Insulin detemir: a review of its use in the management of diabetes mellitus.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

7.  Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics.

Authors:  Jean-Pierre Le Floch
Journal:  Diabetes Metab Syndr Obes       Date:  2010-06-21       Impact factor: 3.168

8.  Effects of insulin degludec and insulin glargine on day-to-day fasting plasma glucose variability in individuals with type 1 diabetes: a multicentre, randomised, crossover study.

Authors:  Tomoaki Nakamura; Kazuhiko Sakaguchi; Anna So; Shinsuke Nakajima; Michinori Takabe; Hisako Komada; Yoko Okuno; Yushi Hirota; Takehiro Nakamura; Keiji Iida; Michiko Kajikawa; Masao Nagata; Wataru Ogawa; Susumu Seino
Journal:  Diabetologia       Date:  2015-06-05       Impact factor: 10.122

9.  Evaluation of the incidence and risk of hypoglycemic coma associated with selection of basal insulin in the treatment of diabetes: a Finnish register linkage study.

Authors:  Jari Haukka; Fabian Hoti; Panu Erästö; Tero Saukkonen; Sari Mäkimattila; Pasi Korhonen
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-10-21       Impact factor: 2.890

10.  Minimal functional β-cell mass in intraportal implants that reduces glycemic variability in type 1 diabetic recipients.

Authors:  Pieter Gillard; Robert Hilbrands; Ursule Van de Velde; Zhidong Ling; Da Hae Lee; Ilse Weets; Frans Gorus; Christophe De Block; Leonard Kaufman; Chantal Mathieu; Daniel Pipeleers; Bart Keymeulen
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.